Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00378846
Other study ID # 060118
Secondary ID 06-C-0118NCI-P68
Status Completed
Phase N/A
First received September 19, 2006
Last updated March 14, 2012
Start date March 2006
Est. completion date November 2009

Study information

Verified date March 2012
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

RATIONALE: Comparing results of three different thermometers used to measure body temperature may help doctors find the most accurate thermometer to detect fever and plan the best treatment.

PURPOSE: This clinical trial is studying three different types of thermometers to measure temperature in young patients with fever and without fever.


Description:

OBJECTIVES:

Primary

- Determine agreement between three different types of temperature-measuring instruments: the temporal artery scanner, the digital oral thermometer, and the infrared tympanic thermometer calibrated to an oral setting, in pediatric patients who are febrile and afebrile.

Secondary

- Determine similarities or differences in the percent of fevers detected with oral, ear, and temporal artery monitoring in these pediatric patients.

- Determine differences in agreement of the various temperature devices in non-neutropenic pediatric patients versus neutropenic pediatric patients.

OUTLINE: This is a prospective study.

During an afebrile episode, the patient's temperature is measured twice using the following 3 devices: a temporal artery scanner, a digital oral thermometer, and an infrared tympanic thermometer calibrated to an oral setting (total of 6 temperature measurements per afebrile episode).

During a febrile episode, the patient's temperature is measured twice using all 3 devices as above, and then at 2 and 4 hours after administration of an antipyretic medication (total of 18 temperatures per febrile episode).

Patients' temperatures are recorded for a maximum of 3 afebrile or febrile episodes.

PROJECTED ACCRUAL: A total of 32 patients will be accrued for this study.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date November 2009
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 4 Years to 17 Years
Eligibility DISEASE CHARACTERISTICS:

- Febrile or afebrile

- Patient at the Mark O. Harfield Clinical Research Center

- Previously enrolled in an IRB-approved Clinical Center protocol

PATIENT CHARACTERISTICS:

- Able to hold an oral thermometer in mouth

- No acute life-threatening infection

- No ear, nose, or throat (aural) abnormalities

- No severe mucositis

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- No concurrent enrollment on a behavioral research study

Study Design

Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Procedure:
infrared thermography


Locations

Country Name City State
United States Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda Maryland

Sponsors (2)

Lead Sponsor Collaborator
National Institutes of Health Clinical Center (CC) National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Agreement between the temporal artery scanner, digital oral thermometer, and infrared tympanic thermometer calibrated to an oral setting in pediatric patients who are febrile and afebrile No
Secondary Similarities or differences in the percent of fevers detected with oral, ear, and temporal artery monitoring No
Secondary Differences in agreement of the various temperature devices No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00020865 - Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Phase 3
Withdrawn NCT00886496 - Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia Phase 1
Completed NCT00003805 - Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Phase 3
Completed NCT00020527 - Caspofungin Acetate in Treating Children With Fever and Neutropenia N/A
Completed NCT00003739 - Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy Phase 3
Terminated NCT00062231 - Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer N/A